Table 2.
Univariate analysis of OS and RFS
| Variables | OS, % | p | RFS, % | p | ||
|---|---|---|---|---|---|---|
| Diseases, mean(95%CI) | ||||||
| AML | 84.8 (71.1, 98.5) | 0.771 | 85.2 (71.9, 98.5) | 0.358 | ||
| ALL | 72.6(51.4, 93.8) | 67.4(47.2, 87.6) | ||||
| HLA matching, mean(95%CI) | ||||||
| 10/10 and 9/10 | 95.7(87.3, 100) | 0.009 | 96.2(88.8, 100) | 0.002 | ||
| 8/10 and 7/10 | 70.7(52.1, 89.3) | 59.3(39.5, 79.1) | ||||
| PTCY, mean(95%CI) | ||||||
| Yes | 70.9(51.5, 90.3) | 0.057 | 67.5(49.3, 85.7) | 0.075 | ||
| No | 89.9(76.6, 100) | 90.5(77.5, 100) | ||||
| Remission, mean(95%CI) | ||||||
| CR1 | 86.0(75.4, 96.6) | 0.011 | 86.6(96.8, 76.4) | < 0.001 | ||
| CR2 | 60.0(17.1, 100) | 0 | ||||
AML acute myeloid leukemia, ALL acute lymphoblastic leukemia; others, mixed lineage leukemia, CR1 first complete remission, CR2 second complete remission, HLA human lymphocyte antigen, PTCY posttransplant cyclophosphamide, GvHD graft-versus-host-disease, PES peri-engraftment syndrome, OS overall survival, RFS Relapse-free survival, SE Standard error, 95%CI 95% confidence interval